Brief: Onxeo Receives Notice Of Intent To Grant New Patent
Oct 22 (Reuters) - ONXEO SA C4X.PA :
* ONXEO RECEIVES NOTICE OF INTENT TO GRANT A NEW PATENT
ENHANCING
THE PROTECTION IN EUROPE OF ASIDNA™ COMBINED WITH PARP
INHIBITORS
* THIS PATENT WILL PROVIDE A TERM OF PROTECTION UNTIL 2036
Source text for Eikon: ID:nGNX2q2jBp
Further company coverage: C4X.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587785110;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln